Built for AI & Data Science leaders in pharma

Ship your pharma AI pilot to production in 90 days.

Quome is the senior services team + HIPAA-ready platform your data scientists have been asking for. We deliver production-grade AI apps and agents — inside your own AWS, GCP, or Azure account — ready for validation on day one.

90 days
Pilot to production
20+
Data scientists & agent engineers
HIPAA
Ready · BAA available
0%
Enterprise churn to date

Your pilots never reach production.

Your data scientists built something that works in a notebook months ago. It's still in a notebook. The production data they need is behind a 6-month IT ticket. Your compliance team won't greenlight PHI access without an architecture review that's been waiting for a platform team hire since last year. The Series A-style vendors can't sign a BAA, and the Big Four can't move faster than 18 months — so the pilot goes back on the shelf, and your VP asks again why pharma AI is so slow.

You don't need another model, another warehouse, or another consulting deck. You need a team that's done this before and a platform built for regulated pharma workloads from day one — so the next pilot your team builds gets validated, deployed, and measured inside this fiscal year.

What we deliver

A senior services engagement and a production platform — together — so your pilot ships to production in a single quarter, not a single fiscal year.

Senior team, embedded

20+ data scientists, agent engineers, and security experts who ship. Your pilot gets a dedicated engineering lead who owns the roadmap from kickoff to production cutover — no handoffs, no ticket queues.

Platform on your cloud

The finished app or agent runs inside your AWS, GCP, or Azure account. Your data never leaves. Your IAM controls access. Your billing, your audit logs, your SOC 2 perimeter — extended, not replaced.

HIPAA-ready from day one

Signed BAA. 4-layer tenant isolation. Full audit trail. 24 documented security policies. SOC 2 Type I audit in progress. Your compliance team can start validation the week the pilot goes live.

Why not the other options?

Every pharma AI leader we talk to has already tried — or been pitched — these approaches. Here's why they stall.

Approach
What you get
What it costs you
Hire an internal AI team
Full control, long-term IP
12–18 months and $3–5M before your first pilot ships. Platform still needs to be built.
Big consulting (Accenture, Deloitte, IQVIA)
Delivery muscle, pharma domain
18-month SOW, 7-figure price tag, zero platform IP, zero continuity when the consultants leave.
Generic AI vendors
Polished demo, fast PoC
No signed BAA. No pharma validation path. Data leaves your cloud. Won't survive a compliance review.
Quome
Production pharma AI in 90 days — on your cloud, under BAA, with a platform you keep owning after the engagement ends.

Built for PHI and IP

Four layers of tenant isolation. A compromise of one workload has zero impact on any other. Every project you run on Quome is isolated at the cloud account, identity, application, and network layers.

1

Cloud Account

Per-project cloud account / subscription.

Dedicated Postgres, Redis, compute, storage, KMS — provider-enforced. Clinical data never shares infra with commercial data.

2

Credential

Each project has its own delegate identity; cross-project token exchange impossible.

AWS external_id, GCP audience binding, Azure tenant federation — zero stored long-lived credentials.

3

Control Plane

Row-level security + SpiceDB authorization on every resource access.

Every access to PHI or proprietary molecule data is logged, authorized, and auditable.

4

Network

Three-zone segmentation; databases never internet-accessible.

Public (LB only) / Application (VPC connector, no public IP) / Data (private only).

Zero stored credentials · 1-hour max tokens

Quome never stores long-lived customer credentials. Every access to your cloud uses a short-lived token minted via your delegate identity — so your security team has one less thing to worry about during validation.

Compliance posture

24 security policies documented and enforced · SOC 2 Type I audit in progress with Prescient

HIPAA
Ready · BAA available
SOC 2 Type I
In progress — Q2 2026
SOC 2 Type II
Planned — Q4 2026
OWASP ASVS L3
Aligned
NIST 800-57
Key lifecycle compliant
FIPS 140-2
Level 2/3 HSMs
SLSA
Level 3 provenance
TLS 1.3 / mTLS
Control ↔ Data plane

Two ways to start

Kick the tires on the platform, or let our team drive the first pilot end-to-end. Most pharma customers do both.

Platform Trial
30 days
Free · No credit card

Your team deploys apps, agents, and data services inside your own AWS, GCP, or Azure account. Unlimited projects, sandboxes, and models during the trial.

  • Multi-cloud deploy (AWS · GCP · Azure)
  • Isolated AI sandboxes & model gateway
  • Production Postgres & object storage
  • Fine-grained authorization on every resource
Terry's focus
90-Day Services Engagement
Custom
Fixed-scope delivery · Signed BAA

Our senior data scientists and agent engineers take your pilot from discovery to production cutover in 90 days. You keep the code, the models, and the platform after the engagement ends.

  • App-as-a-Service · Agent-as-a-Service
  • Data-as-a-Service · Support-as-a-Service
  • Dedicated engineering lead & private Slack
  • Phased delivery with weekly demos

Most pharma customers start with a 30-day trial to validate the platform, then move into a 90-day services engagement for the first production pilot.

Let's talk about your pilot.

30 minutes with Terry, our CRO. We'll walk through the pilot you're trying to ship, the blockers, and whether a 90-day engagement is the right shape — or whether a 30-day platform trial gets you there first.

You'll leave with: a candid read on feasibility · a rough scope & timeline · next-step options (no deck, no pressure).

Calendar not loading? Open scheduling in a new tab →

Stop running pilots. Start shipping pharma AI.

Keep your cloud. Keep your compliance posture. Keep your data. Quome gives you the team and platform to put it all to work.

Book 30 min with Terry →